Related Experiment Video
Updated: Aug 21, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Hepatitis C-HIV coinfection: current and future therapy
Jagdeep J Vyas1, Robert S Brown, Paul J Gaglio
1Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, NY, NY 10032, USA.
Abstract:
Coinfection with hepatitis C in HIV-infected patients has been reported in 15-70% of patients depending on the mode of acquisition of both viruses. As recent advances in HIV-directed antiviral therapy have markedly delayed HIV progression and mortality, the incidence of complications arising from hepatitis C-associated liver disease in coinfected patients is increasing exponentially. The interaction of HIV and hepatitis C is complex. It is clear that HIV infection negatively affects the natural history of hepatitis C, while HIV-directed therapy may enhance immunologic response and exacerbate hepatocellular injury induced by hepatitis C via immune reconstitution. In this review, the pathobiology, inter-relation of hepatitis C and HIV infection in coinfected patients as well as present and future treatment in this unique patient population are discussed.
Related Concept Videos
Retrovirus Life Cycles
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Sexually Transmitted Infections
Inhibitors of Virion Maturation and Assembly